Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04947735 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CYPRESS Efficacy and Safety Study Extension

Study acronym: CYPRESS
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Apr 30, 2025 to Oct 31, 2026
    • Study completion date: Mar 31, 2026 to Dec 31, 2026
    v7
  2. Study completion date: Jun 30, 2025 to Mar 31, 2026v6
  3. Study sites revised (12)v5
  4. Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 11 to 12
    v4
  5. Re-verified, no change to tracked fieldsv3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised at 11 of 11 sites
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is an open-label, controlled, multisite, two-arm parallel group clinical trial of 36-month duration to evaluate the continued safety and efficacy of SightGlass Vision Diffusion Optics Technology (DOT) Spectacles in reducing the progression of juvenile myopia.
Trial Details
NCT Number NCT04947735
Lead Sponsor SightGlass Vision, Inc.
Conditions
(from sponsor)		 Juvenile Myopia, Myopia
Related terms Myopia
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov